Dirk Gillé, VP – R&D Fellowship Development Leader – Global Public Health
Dirk has more than 30 years of experience in drug development. Amongst other Dirk was Clinical & Compound development team member in the dermatology franchise at the Janssen Research Foundation. Later he has set up the medical departments in Central & Eastern Europe from a Pharmacovigilance and Clinical Development perspective, integrating the region in the development organization. In 1999, Dirk left J&J and joined Tibotec as Senior Director of Global Clinical Operations, creating a worldwide structure for Clinical Operations and Quality Management. After Tibotec was acquired by J&J, he drove the development of the New Operating Model for the newly created GCO organization. In 2009, Dirk became the Global Head of Quality Management & Training, responsible for implementing a clinical QMS that created efficiencies and enhanced compliance in the clinical arena for the newly created Janssen R&D organization. In 2012 he became Global Head of the Janssen R&D Quality Assurance organization, responsible for the audit programs in the non-regulated, GLP, GCP and PV domains.
Since Oct 2017, Dirk joined J&J R&D Global Public Health as R&D Fellowship Development Leader, responsible for capacity building initiatives that should facilitate the execution of the R&D GPH programs and support capacity building in resource limited settings.
Dirk has two Master’s degrees, both from Catholic University of Leuven; one in Physical Education and one in Physiotherapy. He also has two post-graduate degrees, one in Dermato-cosmetic Sciences and one in Business Management. He is ISO 31000 Risk Management certified. Dirk is based in Beerse, Belgium.